Phenotypes associated with this allele
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Lyz2tm1(cre)Ifo mutation
(14 available);
any
Lyz2 mutation
(41 available)
Ptpmt1tm2.1Ckq mutation
(0 available);
any
Ptpmt1 mutation
(12 available)
|
|
|
cellular
|
• macrophages exhibit decreased mitochondrial aerobic metabolism at basal levels and maximal reserve capacities compared with control cells
|
hematopoietic system
N |
• mice exhibit normal myeloid, T lymphoid and B lymphoid lineages and cell cycle of lineage progenitors
|
immune system
N |
• mice exhibit normal myeloid, T lymphoid and B lymphoid lineages and cell cycle of lineage progenitors
• macrophages exhibit normal growth and cell cycle
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cd19tm1(cre)Cgn mutation
(11 available);
any
Cd19 mutation
(56 available)
Ptpmt1tm2.1Ckq mutation
(0 available);
any
Ptpmt1 mutation
(12 available)
|
|
|
hematopoietic system
N |
• mice exhibit normal myeloid, T lymphoid and B lymphoid lineages and cell cycle of lineage progenitors
|
immune system
N |
• mice exhibit normal myeloid, T lymphoid and B lymphoid lineages and cell cycle of lineage progenitors
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptpmt1tm2.1Ckq mutation
(0 available);
any
Ptpmt1 mutation
(12 available)
Tg(Lck-cre)1Cwi mutation
(3 available)
|
|
|
hematopoietic system
N |
• mice exhibit normal myeloid, T lymphoid and B lymphoid lineages and cell cycle of lineage progenitors
|
immune system
N |
• mice exhibit normal myeloid, T lymphoid and B lymphoid lineages and cell cycle of lineage progenitors
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptpmt1tm2.1Ckq mutation
(0 available);
any
Ptpmt1 mutation
(12 available)
Tg(Mx1-cre)1Cgn mutation
(7 available)
|
|
|
mortality/aging
|
• most mice die within 2 to 3 weeks of pIpC treatment
|
hematopoietic system
N |
• hematopoietic stem cells in pIpC-treated mice exhibit normal apoptosis rates
|
|
• decreased bone marrow myeloid and lymphoid progenitors in pIpC-treated mice
|
|
• severe in pIpC-treated mice
|
|
• decreased bone marrow myeloid and lymphoid progenitors in pIpC-treated mice
|
|
• increased hematopoietic stem cells and multipotent progenitors in the bone marrow of pIpC-treated mice
|
|
• hematopoietic stem cells (HCS) from pIpC-treated mice fail to differentiate in colony forming assays
• cell-autonomous defect in differentiation and blocked repopulating capabilities in HCS from pIpC-treated mice
• HSCs from pIpC-treated mice accumulate at the G1 phase and exhibit enhanced entry of quiescence
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ptpmt1tm2.1Ckq mutation
(0 available);
any
Ptpmt1 mutation
(12 available)
Tg(VAV1-cre)1Graf mutation
(1 available)
|
|
|
mortality/aging
|
• within 5 to 9 days of birth
• however, mice can be rescued by transplantation of wild-type bone marrow cells
|
hematopoietic system
|
• 30-fold; develops gradually
|
immune system
endocrine/exocrine glands